SHARE

Derek Peterson, the Chief executive of Terra Tech Corp (OTCMKTS:TRTC), stated that in 2014 the company made a promise to its shareholders to expand gross margins. The company confirmed that they have achieved significant progress in the first quarter of year with the launch of cannabis concentrates. The product has substantial margins which will boost the performance of company in coming quarters. Also, the management took several measures in the quarter to reduce operating costs at EG.

The reinvestment of funds

The CEO of Terra Tech further said that IVXX must operate as a not for profit unit in California. It is the prime reason the funds generated from respective brand is reinvested back. It is done in order to meet compliance and regulations as applicable in California. The reinvestment of funds helps the company to reduce cash burn and support the development plans of infrastructure. Also, there is no need to raise additional capital, avoiding massive dilution of shareholders.

The initiatives

The management of Terra Tech is working in association with the California legislation to create a for-profit platform. It will work to expand company’s brand across the largest medical cannabis market in the country. One of the other target areas is Nevada State, which again is for-profit environment. Terra Tech has been working hard to achieve longevity in brand development.

The achievements

The company reported that IVXX manufactured and transported cannabis concentrates in 1Q2015. The premium product was dispatched to numerous medical marijuana dispensaries in the State of California. The subsidiary Edible Garden firm also achieved success in expanding its footprint in Walmart stores.

In last trading session, the stock price of Terra Tech declined more than 3% to close the trading session at $0.1416. The decline came at a share volume of 2.25 million compared to average share volume of 1.08 million.

SHARE
Previous articleAMARANTUS BIOSCI INC (OTCMKTS:AMBS) Plans To List On NASDAQ
Next articleWhat Is The Buzz Surrounding Titan Pharmaceuticals, Inc. (OTCMKTS:TTNP)?
Steve Kanaval: Portfolio Manager/Writer/ Market Analyst Steve began his career in the Trading Pits in Chicago making markets at the Chicago Mercantile Exchange (NYSE:CME) the Chicago Board of Trade and the CBOE in the early 80’s. He ran the Morgan Stanley Derivative Prop Trading for the firm specializing in Index Arbitrage. He continued his career as a Trader/Portfolio Manager for multiple Hedge Funds during the Internet Boom of the 90’s managing large portfolios. Steve is known as an expert in MicroCap Technology Stocks and the emerging Digital Currency markets as a Portfolio Manager for his Family Office. Steve has managed portfolio’s in volatile asset classes for 3 decades as a commodity trader, hedge fund manager and digital currency trader and miner. Steve publishes his views on the asset classes in a public forum and has published more than 10,000 articles simplifying these complex and volatile assets for readers. His work is published on multiple sites including Bloomberg, Equities.com, Hacked.com, CryptoCurrencyNews as a paid contributor. His work includes research, journalism and archived video on important market volatility related to stocks, digital currency and other volatile misunderstood asset classes. He offers a humorous, unique insight and the related back stories and drivers for readers interested in volatility and emerging market assets. Full disclosure Steve is long 25 digital currencies and sits on the board of multiple public companies involved in digital currencies, and owns shares in these companies from time to time.